International Stem
Cell Corp., a California-based biotechnology company developing novel stem cell
based therapies and biomedical products, announced that it will host a
conference call next with to provide a business update and discuss its
financial results for the three months ended March 31, 2014.
Dr. Simon Craw,
Executive Vice President, and Mr. Jay Novak, Chief Financial Officer of
International Stem Cell, will be hosting the upcoming conference call. To
attend the call, please use the dial in information below:
Date: Wednesday, May
14, 2014
Time: 11:00 a.m.
Eastern Time
Conference Number
(U.S.): 1-877-941-2069
International
Dial-In: 1-480-629-9713
Conference ID:
4682485
Webcast:
http://public.viavid.com/confirmation/confirmwebcast.php?id=o5aroJyX
Participants are
advised to dial in at least 10 minutes before the call to ensure timely
participation.
A playback of the
call will be available from 05/14/14 at 5:00 pm ET until 05/28/14 at 11:59 pm
ET. To listen, call 1-877-870-5176 within the United States or 1-858-384-5517
when calling internationally. Please use the replay pin number 4682485.
For more
information, visit www.internationalstemcell.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
No comments:
Post a Comment